Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
BMC Bioinformatics
|
June 20, 2018
Performance of epistasis detection methods in semi-simulated GWAS
Clément Chatelain, Guillermo Durand, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
An Allosteric Ribozyme Regulated by Doxycyline
Nicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)
|
October 10, 2001
An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support
Nicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2002
Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletal muscle and heart
Raphaël Darteil, Manping Wang, Martine Latta-Mahieu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 4, 2004
Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation
Semi Tascou, Tine-Kring Sorensen, Valérie Glénat, et al.
Human Gene Therapy
|
September 14, 2002
Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression
Martine Latta-Mahieu, Magali Rolland, Catherine Caillet, et al.
British Journal of Cancer
|
September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
Diether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation
Malidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
BMC Bioinformatics
|
June 20, 2018
Performance of epistasis detection methods in semi-simulated GWAS
Clément Chatelain, Guillermo Durand, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)
|
May 2, 2018
An Allosteric Ribozyme Regulated by Doxycyline
Nicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Angewandte Chemie (International Ed. in English)
|
October 10, 2001
An Allosteric Ribozyme Regulated by Doxycyline This work was supported by Aventis Gencell and by a grant from the Volkswagen Foundation (Priority program "conformational control") to M.F. We thank M. Blind, G. Mayer, D. Proske, and G. Sengle (Universität Bonn) for helpful discussions as well as J. Crouzet, J. F. Mayaux, and M. Finer (Aventis Gencell) for support
Nicolas Piganeau, Andreas Jenne, Vincent Thuillier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 6, 2002
Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletal muscle and heart
Raphaël Darteil, Manping Wang, Martine Latta-Mahieu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 4, 2004
Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation
Semi Tascou, Tine-Kring Sorensen, Valérie Glénat, et al.
Human Gene Therapy
|
September 14, 2002
Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression
Martine Latta-Mahieu, Magali Rolland, Catherine Caillet, et al.
British Journal of Cancer
|
September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
Diether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Clinical Pharmacology and Therapeutics
|
April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation
Malidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Page
of 1